Background Prolonged nitrate therapy during healing between 2 days and 6 weeks after anterior myocardial infarction has the potential for limiting further left ventricular remodeling (or changes in topography) and preserving function. Longterm therapy throughout healing over 6 weeks might be more beneficial than short-term therapy over the first 2 weeks after infarction.
Background Prolonged nitrate therapy during healing between 2 days and 6 weeks after anterior myocardial infarction has the potential for limiting further left ventricular remodeling (or changes in topography) and preserving function. Longterm therapy throughout healing over 6 weeks might be more beneficial than short-term therapy over the first 2 weeks after infarction.
Methods and Results The effect of prolonged nitrate therapy between 2 days and 6 weeks during healing after infarction on serial parameters of ventricular remodeling (scar expansion, scar thinning, ventricular dilation, and hypertrophy) and function (asynergy or akinesis plus dyskinesis and ejection fraction) by serial two-dimensional echocardiography, hemodynamics, postmortem topography (computerized planimetry, geometric maps, and radiographs), and collagen content (hydroxyproline) was studied in 64 instrumented dogs randomized 2 days after left anterior descending coronary artery ligation to various nitrate regimens (n=32) over the first 2 weeks (subgroup 1: 2% transdermal nitroglycerin at 8 AM and 4 PM, n=6; subgroup 2: 2% transdermal nitroglycerin plus 2.6 mg of sustained-release oral nitroglycerin at 8 AM, 3 PM, and 10 PM, n=5; subgroup 3: oral isosorbide dinitrate, 30 mg at 8 AM and 4 PM, n=11) or 6 weeks (subgroup 4: isosorbide dinitrate, n= 10 ) and in matching controls (n=32). Nitrate therapy reduced left atrial pressure, mean arterial pressure, and the rate-pressure product compared with controls over the 6 weeks. Postmortem scar mass and hydroxyproline were similar in control and nitrate groups. However, scar stretching and thinning, cavity dilation, noninfarct wall hypertrophy, and apical bulging were less with nitrates, especially in the longterm subgroup 4. In vivo remodeling parameters between 2 days and 6 weeks after ligation showed that, compared with controls, nitrate therapy prevented further stretching of the asynergic segment, decreased the expansion index, decreased further scar thinning, prevented the increase in ventricular volumes, reduced the frequency of ventricular aneurysm, prevented the increase in ventricular mass, reduced the extent of asynergy, and improved ejection fraction. Although the beneficial effect on topography and function was seen in all nitrate subgroups, the overall benefit was greater with longterm therapy over 6 weeks (subgroup 4) than short-term therapy confined to the first 2 weeks (subgroups 1, 2, and 3).
Conclusions Prolonged nitrate therapy, in various regimens during healing after infarction, effectively reduced left ventricular loading and prevented infarct thinning, further infarct expansion, progressive ventricular dilation, and the increase in mass. These effects were associated with decreased asynergy and improved ejection fraction. The beneficial effects were greater with long-term therapy over 6 weeks than short-term therapy over the first 2 weeks. (Circultion. 1994;89:.2297-2307.)
Key Words * infarction * hypertrophy * collagen imitation of postinfarction left ventricular remodeling, or the alterations in topography that L....doften impact negatively on function and survival, is becoming recognized as an important therapeutic goal.1-4 Nitrates after infarction have the potential to salvage left ventricular myocardium, geometry, and function because of their ventricular unloading and flow-promoting properties.5 Despite century-old warnings about nitrate-induced hypotension in acute myocardial infarction6-8 and the development of tolerance with chronic use,9,10 nitrates were successfully applied clinically to treat left ventricular failure1l-13 or to prevent its development14,15 in acute myocardial infarction. Short-term, low-dose intravenous nitroglycerin infusion 
Methods

Experimental Preparation
All experiments were approved by the institutional animal welfare committee and conformed to the guiding principles of the American Physiological Society. Seventy-five healthy mongrel dogs (weight, 16 to 29 kg) of either sex were instrumented through a left lateral thoracotomy under general anesthesia (sodium pentobarbital, 30 mg/kg IV), as described previously. 25 (11 control, 11 nitrate). The dogs were allowed free access to fluids, and no attempt was made to treat heart failure by fluid restriction or pharmacotherapy. At 6 weeks, the 64 surviving dogs (Table 1) were anesthetized, and the hearts were arrested in diastole with an overdose of intravenous potassium chloride, excised, washed in normal saline solution, and weighed. Blood samples were taken for monitoring blood gases, hemograms, and electrolytes. 
Analysis of Echocardiograms
Coded echocardiograms were analyzed on video playback in double-blind fashion by two independent observers at the end of the studies, as described previously.20 Briefly, endocardial and epicardial outlines of the left ventricular images at end diastole and end systole were traced with a light pen (Franklin Quantic 1200 review station or Diasonics CardioRevue Center), corrected on to-and-fro playback over at least three consecutive cycles, and copied on plastic overlays. Anatomic landmarks (papillary muscle, right and left ventricular junctions) were indicated on the tracings. Markings of asynergy, defined as akinesis (no systolic inward motion and thickening), dyskinesis (systolic outward motion and thinning), or both, were made on each endocardial diastolic outline by careful visual assessment of motion and thickening on repeated video playbacks. The circumferential extents on each short-axis view were then digitized (Hewlett-Packard 9878A and 9835A) and used to compute total endocardial surface area of left ventricular asynergy using three-dimensional reconstruction.2028-0 Outlines from five short-axis and two long-axis views were used to compute volumes by means of the modified Simpson's rule.20 Global ejection fraction was calculated as (end-diastolic volume minus end-systolic volume) divided by end-diastolic volume. The interobserver error was less than 5% in marking asynergy, segment length, wall thickness, and areas of outlines, in agreement with previous studies.2028-w0 Topographic measurements were made on end-diastolic outlines of short-axis in vivo echocardiographic images at the papillary level. Expansion index was computed as the ratio of the lengths of the asynergy-containing and the nonasynergy-containing segments. Thinning ratio was computed as the ratio of the average thicknesses of the asynergic and nonasynergic zones. Regional area ejection fraction was calculated at the same level as (end-diastolic area minus end-systolic area) divided by enddiastolic area. The degree of regional bulging in the asynergic zone was characterized at the short-axis papillary level by its area (Ad), depth (rd), and the peak distortion index (Pk), as described previously.2830 Left ventricular aneurysm was defined as the presence of diastolic bulge with further bulging and thinning in systole on the short-axis views at the papillary and apical levels and/or the apical four-and two-chamber views. Left ventricular mass was calculated from the volume of myocardium (difference in volumes of epicardial and endocardial shells at end diastole) multiplied by an assumed specific gravity of 1.05 g/mL.
Statistics
Data at different steps were coded and analyzed in blinded fashion at the end. The following statistical tests were used: ANOVA for the significance of difference within and between groups or subgroups; linear regression analysis by the least square fit method and the significance of r values and slopes by ANOVA; 2x2 x2 and Fisher's exact tests for the significance of difference in event frequency between groups; and repeated-measures ANOVA for comparing serial data within groups.
Results are presented as mean±SE. Statistical significance was set at P<.05.
Results
Data from 64 dogs that survived to the day of scheduled killing and that were randomized to control (n=32) and nitrate (n=32, Table 1 ) groups are presented. Five dogs that died within 2 days of coronary ligation and another 6 dogs that died between day 3 and the scheduled killing were excluded. Data for the control subgroups were similar (P=NS), so pooled control data are presented. For nitrate, the data are either pooled for all subgroups or presented for the pooled short-term (over 2 weeks) therapy subgroups 1, 2, and 3 weeks and long-term (over 6 weeks) therapy subgroup 4 when differences were significant.
Effect on Hemodynamics
Heart rate, mean left atrial pressure, and mean arterial pressure in the two groups were similar after ligation (Table 2 ). There were no marked differences in heart rate between the two groups over the 6 weeks. Nitrate therapy resulted in a prompt and persistent The control group and the nitrate subgroups showed similar degrees of infarct expansion (Fig 3) on the postligation baseline echocardiograms at 2 days. Between preligation and 2 days after ligation, the expansion index increased (P<.01) from 1.9 to 2.2 in the nitrate group and 1.7 to 2.0 in the control group. During postinfarct healing between 2 days and 6 weeks, expansion index increased by a further 3% (P<.025) in the control group and decreased by 6% (P<.025) in the nitrate group, but the persistent decrease was mainly due to the continued decrease in the long-term nitrate subgroup between 3 and 6 weeks (Fig 3) . The infarctcontaining segment length decreased by 3% in the nitrate group but increased by 9% in the control group. Overall, the change in noninfarct-containing segment length did not differ significantly between the two groups. However, the upward trend in lengthening of the infarct-and noninfarct-containing segments between 3 and 6 weeks in the combined nitrate group was due to increases in the short-term nitrate subgroups 1, 2, and 3 (Fig 3) . Effect on In Vivo Changes in Thinning During Healing The control group and nitrate subgroups showed similar degrees of infarct thinning (Fig 4) on the baseline echocardiograms at 2 days after ligation. Between preligation and 2 days after ligation, the thinning ratio decreased (P<.001) from 1.00 to 0.71 in the nitrate group (before therapy) and 0.99 to 0.71 in the control group. During healing, between 2 days and 6 weeks, the thinning ratio decreased by a further 28% (P<.001) in the control group but increased by 20% (P<.001) in the combined nitrate group, with no difference between the short-term and long-term subgroups (Fig 4) . Infarct wall thickness decreased further by 24% (P<.001) in controls but increased by 11% (P<.05) with nitrates. The noninfarct wall thickness showed an overall increase by 7% (P<.05) in controls but did not change with nitrates. No significant thinning was detected in the nitrate subgroups 1, 2, and 3 between 2 and 6 weeks. However, an additional 8% decrease in infarct wall thickness (from -15.5% to -23.6%) occurred during that interval in the control group (Fig 4) and subgroups. The percent changes in the infarct segment length, expansion index, infarct wall thickness, and thinning ratio during healing were markedly different between nitrate and control groups (Figs 3 and 4) as well as in the corresponding subgroups (Table 5 ).
Effect on Changes in Left Ventricular Volumes and Ejection Fraction In Vivo
Left ventricular end-diastolic (80 versus 89 mL) and end-systolic volumes (45 versus 53 mL) in the control and nitrate groups were similar (P=NS) at the postligation baseline (Fig 5) . During healing, the volumes increased in the controls but decreased in the nitrate group (P<.001). Global left ventricular ejection fraction was equally depressed in the two groups at baseline (41% versus 43%) and improved to a greater extent with nitrates than controls, the percent changes by 6 weeks being 29% versus 15% (P<.01) (Fig 5) . The trend for diastolic and systolic volumes to increase in the nitrate group between 3 and 6 weeks, similar to that in the control group, was due to increases in the short-term nitrate subgroups during that interval (Fig 5) . (Fig 6) . The corresponding decreases in the parameters for the combined nitrate group were by 53% and 60%, respectively. There was no significant blunting of the decrease in circumferential or total asynergy in short-term nitrate subgroups 1, 2, and 3 that were off therapy between 2 and 6 weeks. Changes in diastolic and systolic areas and the area ejection fraction (Fig 6) (Fig 7) .
Effect of Duration of Nitrate Therapy
Overall, the improvement in remodeling and functional parameters was greater with long-term therapy over 6 weeks (subgroup 4) than with short-term therapy confined to the first 2 weeks (subgroups 1, 2, and 3). This is illustrated in the summarized data for subgroups 1, 2, and 3 combined versus subgroup 4 for nitrate and control groups in anterior descending coronary artery ligation was used. This resulted in a low mortality rate of 12%, but the infarct scar at 6 weeks was small (9.5% of left ventricular mass), in agreement with previous reports.242527,28,1 As noted previously,31 because the infarct scar contracts and compacts over the 6 weeks, an infarct that is about 19% of left ventricular mass 1 day after coronary ligation is roughly equivalent to 14% at 1 week and 10% at 6 weeks. 25 Nevertheless, in the untreated group, morphometric analysis and infarct mapping showed that the transmural extent at 6 weeks averaged 62%, and echocardiograms revealed infarct-zone akinesis and dyskinesis, expansion, thinning, and aneurysmal bulging and noninfarct-zone hypertrophy and expansion and larger cavity size. A limitation of our canine model is that the dog heart has a rich collateral supply, the infarct-related artery remained permanently ligated, and the noninfarct-related arteries probably remained open throughout infarct healing. Although the chronic nature of the model also prevented direct measurement of initial infarct size, baseline extents of left ventricular asynergy (akinesis plus dyskinesis) were similar in the groups and subgroups, suggesting that initial infarct sizes were similar. Although serial changes in collateral blood flow were also not measured, the possibility that initial infarct size might have changed differentially in the nitrate versus control groups or subgroups between 2 days and 6 weeks seems unlikely because the final scar sizes at 6 weeks were similar for those corresponding groups and subgroups.
Mechanisms of Nitrate Benefit During Infarct Healing
The potential mechanisms for the beneficial effect of nitrates on ventricular remodeling after infarction have been reviewed45 and are complex. The findings in this study are consistent with the notion that the beneficial effects of nitrate were due to left ventricular unloading as a result of dilation of arterial and venous beds. The decrease in preload, afterload, cardiac work, and chamber size probably decreased wall stress (by virtue of the Laplace law) and the mechanical deformation and distension forces, thereby reducing infarct bulging and global cavity dilation.2 It is also possible that nitrates might have increased nutrient collateral blood flow to the healing infarct zone and the spared myocardium in the occluded bed and preserved flow in the nonoccluded bed. The combination of decreased wall stress, increased collateral flow to border zone tissue, and preserved flow to normal myocardium also might have preserved the integrity of the collagen matrix in noninfarcted tissue, including that in the subepicardial rim. There was no adverse effect of nitrates on collagen deposition, measured by total hydroxyproline content, in the infarcted or noninfarcted areas in this study. It is possible that antiplatelet, antithrombotic, and spasmolytic effects of nitrates32,33 contributed in maintaining perfusion.
In this study, nitrates also prevented the increase in left ventricular mass found in the control group. As noted previously,25,31 there was no significant increase in postmortem left ventricular mass by 6 weeks after infarction in this model. However, in vivo left ventricular mass measured by serial echocardiography increased over the 6 weeks in the control group and decreased with nitrate therapy. More important, the effect was greater with long-term than short-term therapy.
A similar beneficial effect of prolonged nitrate therapy on left ventricular mass and volume was found in a recent study34 in which isosorbide mononitrate was given twice daily for 16 weeks after myocardial damage produced by transmyocardial DC shock in dogs. In that study,34 nitrate therapy in 10 dogs prevented both the increase in left ventricular mass and volume measured in a group of controls (4 randomized and 13 from a prior study) between 1 and 6 weeks using nuclear magnetic resonance. Also in that study,34 nitrate therapy was associated at 16 weeks with a decrease in pulmonary capillary wedge pressure but not mean aortic pressure, suggesting that the beneficial effects were mainly due to the decrease in preload, volume, and wall stress. However, most of the increase in mass in that study34 occurred by 1 It should be noted that, in contrast with that study,34 the control group in our study showed significant increases in noninfarct wall thickness and left ventricular volume as mass increased by 1 week and that these increases persisted over the 6 weeks in the control group but were prevented in the nitrate group. Apart from the difference in the mode of myocardial damage between that study34 and ours, other pertinent differences in that study were that (1) hemodynamics were measured under sedation or anesthesia, and mass and volumes were measured under anesthesia, (2) these measurements were only made at baseline, 1 week, and 16 weeks, (3) randomization was to 10 treated and 4 control dogs plus 13 more no-treatment dogs from a previous study, (4) detailed, serial in vivo measurements of geometry and function were not made, (5) postmortem topography, morphometry, and collagen were not measured, and (6) short-term and long-term therapy targeted to phases of healing after injury were not compared.
Although chronic nitrate administration produces tolerance, all four nitrate regimens in this study were beneficial. Intermittent therapy (subgroups 1, 3, and 4) and sustained therapy (subgroup 2) successfully attenuated multiple parameters of remodeling. In a recent report, Pipilis et a138 found that 20 mg of isosorbide mononitrate in regular doses three times daily to patients after suspected myocardial infarction did not produce sustained hemodynamic effects. However, they did not measure remodeling parameters. In contrast, intermittent and eccentric nitrate dosing regimens were found to have sustained beneficial effects on remodeling parameters and function in preliminary reports of two randomized clinical studies.21-23 Although tolerance develops within an hour in vitro when large concentrations are used, the effects of nitrates are known to last much longer in patients in whom much lower concentrations are used. In this study, attenuation of the hemodynamic effects was detectable after 1 week but was only partial.
Timing and duration of nitrate therapy also appeared to significantly influence the magnitude of the benefits. Because healing after infarction is not completed for about 6 weeks in dogs and 3 to 6 months in humans, it is logical to propose that "antiremodeling" therapy would be expected to be potentially more beneficial if applied throughout the healing phase than if applied for only a fraction of that time.2,25 In addition, because infarct expansion occurs early and collagen deposition into the already-expanded segments tends to make the shape deformation permanent,25 it would seem logical to begin therapy before collagen deposition plateaus at about 2 weeks.2 In this study, both therapies for the first 2 weeks and 6 weeks were beneficial, but therapy over 6 weeks imparted greater benefits. In fact, there was a suggestion that discontinuation of therapy at 2 weeks might be followed by further remodeling. However, short-term and long-term therapy had nearly similar beneficial effects on reducing infarct thinning, the extent of asynergy, and the frequency of apical aneurysm. Clinical Relevance First, the results of this study indicate that further remodeling occurs after the infarction process is completed and that this can be attenuated by chronic nitrate therapy. Second, the results indicate that both early short-term and long-term therapies during postinfarct healing are beneficial but that the benefit is greater with therapy applied throughout healing. Third, the results provide rationale for the clinical application of prolonged nitrate therapy after infarction to limit remodeling and preserve function.
Several preliminary clinical21-23 studies have focused on the effects of prolonged nitrate therapy between 48 hours and 6 weeks after infarction and after low-dose intravenous nitroglycerin for the 48 hours with or without thrombolytic therapy. These studies21-23 also suggested beneficial effects on ventricular remodeling and function as well as clinical outcome. The recently completed ISIS-4 trial39)40 explored the effect of very early intravenous magnesium followed by isosorbide mononitrate and/or captopril on mortality in patients with suspected infarction. The preliminary results presented at the American Heart Association Meeting in November 199340 indicated that, in a heterogenous (some low-risk patients with inferior or no infarction) and highly selected group of patients, most of whom had already benefited from fibrinolytic and/or intravenous nitrate therapy and subsequently received other concurrent medications at the discretion of the responsible physician, the 35-day mortality in the placebo group was low (6.92% to 7.33%), and the decrease in mortality with oral isosorbide-5-mononitrate (60 mg qd for 28 days) was not statistically significant (7.22% versus 6.98%, P=NS). However, they also reported40 that the decrease in mortality with oral captopril (50 mg bid for 28 days) was significant (7.33% versus 6.87%, P=.04), and the increase in mortality with intravenous magnesium sulfate over the first 24 hours was not significant (6.92% versus 7.28%, P=NS). Effects on left ventricular remodeling were not studied. 40 The beneficial effect of captopril on some postinfarction remodeling parameters has already been documented experimentally in the canine model31 and clinically.4' Because of proven antianginal effects, nitrates might also be expected to reduce postinfarction angina and associated cardiovascular events.
Conclusions
Prolonged nitrate therapy after anterior myocardial infarction is effective in limiting progressive topographic changes during remodeling and interrupts the vicious cycle of more expansion, thinning, ventricular dilation, and aneurysm formation in the dog model. Prolonged therapy throughout healing provides greater benefit than an early pulse of therapy. Nitrate tolerance was minimized and was only partial with the eccentric dosing regimens that have been suggested to provide a daily nitrate-free interval. Further clinical studies are needed to assess the effect of chronic nitrate therapy on postinfarct survival.
